{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T06:02:37Z","timestamp":1740981757754,"version":"3.38.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1997,7]]},"DOI":"10.1136\/ard.56.7.405","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T00:32:33Z","timestamp":1228523553000},"page":"405-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Changes in bone mineral density in patients with Paget\u2019s disease treated with risedronate"],"prefix":"10.1016","volume":"56","author":[{"given":"Sanjeev","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Bhallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Maslanka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Hosking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"doi-asserted-by":"crossref","unstructured":"Campbell G, Compston J, Crisp A, eds (1993) The management of common metabolic bone disorders. (Cambridge University Press, London).","key":"10.1136\/ard.56.7.405_bib1","DOI":"10.1017\/CBO9780511570254"},{"unstructured":"Nordin BEC, Need AG, Morris HA, eds (1993) Metabolic bone and stone disease. (Churchill Livingstone, London).","key":"10.1136\/ard.56.7.405_bib2"},{"key":"10.1136\/ard.56.7.405_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2165\/00003495-199346040-00003","article-title":"Drugs used in the treatment of metabolic bone disease","volume":"46","author":"Patel","year":"1993","journal-title":"Drugs"},{"key":"10.1136\/ard.56.7.405_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0169-6009(89)90021-4","article-title":"Dichloromethylene bisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.","volume":"6","author":"Flanagan","year":"1989","journal-title":"Bone and Mineral"},{"key":"10.1136\/ard.56.7.405_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI114459","article-title":"Bisphosphonate directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.","volume":"85","author":"Carano","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.56.7.405_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0026-0495(89)90260-6","article-title":"Diphosphonates inhibit human osteoblasts secretion and proliferation.","volume":"38","author":"Khokher","year":"1989","journal-title":"Metabolism"},{"key":"10.1136\/ard.56.7.405_bib7","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonate act on rat osteoclast bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahini","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.56.7.405_bib8","first-page":"1397","article-title":"Prospective use of bisphosphonate compounds in osteoporosis.","volume":"76","author":"Fleisch","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.56.7.405_bib9","first-page":"1399","article-title":"The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodelling in early postmenopausal women.","volume":"76","author":"Harris","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.56.7.405_bib10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.55.10.700","article-title":"Current and potential future drug treatments for osteoporosis.","volume":"55","author":"Patel","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.7.405_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/8756-3282(96)00211-6","article-title":"Paget\u2019s disease and osteoclast biology.","volume":"19","author":"Roodman","year":"1996","journal-title":"Bone"},{"key":"10.1136\/ard.56.7.405_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJM196901232800405","article-title":"Skeletal renewal and metabolic bone disease.","volume":"280","author":"Harris","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.56.7.405_bib13","series-title":"Paget\u2019s disease of bone.","article-title":"Paget\u2019s disease of bone: assessment and management.","author":"Hamdy","year":"1981"},{"key":"10.1136\/ard.56.7.405_bib14","first-page":"134","article-title":"Relationship between signs and symptoms in Paget\u2019s disease of bone.","volume":"226","author":"Harinck","year":"1986","journal-title":"Q J Med"},{"key":"10.1136\/ard.56.7.405_bib15","series-title":"Kanis JA. Pathophysiology and treatment of Paget\u2019s disease of bone.","article-title":"Pathophysiology and histopathology.","author":"Kanis","year":"1991"},{"key":"10.1136\/ard.56.7.405_bib16","first-page":"286","article-title":"Measurement of bone density with dual-energy x-ray absorptiometry (DEXA).","volume":"267","author":"Kellie","year":"1992","journal-title":"JAMA"},{"key":"10.1136\/ard.56.7.405_bib17","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/art.1780361203","article-title":"Current methods and recent advances in the diagnosis of osteoporosis.","volume":"36","author":"Jergas","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.56.7.405_bib18","first-page":"110","article-title":"Precision of total-body and regional bone mineral measurement by dual-energy X-ray absorptiometry.","volume":"9","author":"Seto","year":"1991","journal-title":"Radiat Med"},{"key":"10.1136\/ard.56.7.405_bib19","first-page":"359","article-title":"Total body and regional bone mineral analysis by dual - photon absorptiometry in Paget\u2019s disease of bone.","volume":"3","author":"Nuti","year":"1988","journal-title":"Bone and Mineral"},{"key":"10.1136\/ard.56.7.405_bib20","series-title":"Osteoporosis.","first-page":"1451","article-title":"Effect of the bisphosphonates EHDP and APD on bone mineral density in patients with Paget\u2019s disease In: Christiansen C, et al, eds.","author":"Guesens","year":"1990"},{"key":"10.1136\/ard.56.7.405_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jbmr.5650080212","article-title":"Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget\u2019s disease with pamidronate disodium.","volume":"8","author":"Price","year":"1993","journal-title":"J Bone Miner Res"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724402264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724402264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.56.7.405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T02:52:36Z","timestamp":1740970356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724402264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["S0003496724402264"],"URL":"https:\/\/doi.org\/10.1136\/ard.56.7.405","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1997,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in bone mineral density in patients with Paget\u2019s disease treated with risedronate","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.56.7.405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}